Cite
HARVARD Citation
Mitra, D. et al. (2021). Abrogating GPT2 in triple‐negative breast cancer inhibits tumor growth and promotes autophagy. International journal of cancer. 148 (8), pp. 1993-2009. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mitra, D. et al. (2021). Abrogating GPT2 in triple‐negative breast cancer inhibits tumor growth and promotes autophagy. International journal of cancer. 148 (8), pp. 1993-2009. [Online].